ULUSLARARASI YAYINLAR
1. Beksaç M, Waage A, Bringhen S, Kristinsson SY, Sucak G, Gimsing P, Giulia
L, Tuglular TF, Juliusson G, Turesson I, Palumbo A. Does Low Molecular
Weight Heparin Influence The Anti-Myeloma Effects Of Thalidomide? A
Retrospective Analysis On Data From The GIMEMA, Nordic and Turkish
Myeloma Study Groups Acta Haematologica (baskıda)
2. Yegin ZA, Iyidir OT, Demirtaş C, Suyanı E, Yetkin I, Paşaoğlu H, Ilhan
C, Sucak GT. The interplay among iron metabolism, endothelium and
inflammatory cascade in dysmetabolic disorders. J Endocrinol Invest. 2014 Sep
23. [Epub ahead of print]
3. Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L, Blaise
D, Milpied
N, Sucak
G, Sureda
A, Thomson
K, Vandenberghe
E, Vitek
A, Dreger P. Allogeneic and Autologous Stem Cell Transplantation for
hepatosplenic T cell lymphoma: A retrospective study of the EBMT Lymphoma
Working party. Leukemia. 2014 Sep 19. doi: 10.1038/leu.2014.280. [Epub ahead
of print]
4. Salihoglu
A, Elverdi
G, Karadurmus
T, Karadogan
N, Akyol
G, Kaynar
I, Paydas
L, Yegin
S, Ozdemir
Z, Sucak
E, Erdem
G, Ozkocaman
V, Topcuoglu P, Ozcan M, Birtas E, Göker H, Başlar Z, Ferhanoglu B.
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience
in Turkey. Ann Hematol. 2014 Sep 18. [Epub ahead of print]
5. Aygencel G, Türkoğlu M, Türköz Sucak G, Benekli M. Prognostic factors in
critically ill cancer patients admitted to the intensive care unit. J Crit Care. 2014
Aug;29(4):618-26.
6. Pamukçuoğlu M, Emmez H, Tunçcan OG, Oner AY, Cırak MY, Senol E, Sucak
GT. Brain abscess caused by Nocardia cyriacigeorgica in two patients with
multiple myeloma: novel agents, new spectrum of infections. Hematology. 2014
Apr;19(3):158-62.
7. Kadir Acar, Şahika Zeynep Akı, Zübeyde Nur Özkurt, Gülendam Bozdayı,
Seyyal Rota, Gülsan Türköz Sucak Factors Associated with Cytomegalovirus
Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation:
Human Leukocyte Antigens Might Be Among the Risk Factors Turk J Haematol.
2014 Sep 5;31(3):276-285
1
8. Abdülkerim Yıldız, Merih Kızıl Çakar, Elif Suyanı, Gülsan Türköz Sucak A
Systemic Lupus Erythematosus Patient with Isolated Neutropenia and
Diminished Expression of CD55 and CD59 Similar to Paroxysmal Nocturnal
Hemoglobinuria doi: 10.4274/Tjh.2013.0318 Pages 323 – 324
9. Suyanı E, Sucak GT, Akyürek N, Sahin S, Baysal NA, Yağcı M, Haznedar R.
Tumor-associated macrophages as a prognostic parameter in multiple myeloma.
Ann Hematol. 2013 May;92(5):669-77
10. Akyol A, Nazlıel B, Batur Caglayan HZ, Oner Y, Sucak GT. Recurrent
Transient Ischemic Attacks in a Patient with POEMS Syndrome. Case Rep
Neurol Med 2014:158471
11. Boyacı N, Aygencel G, Turkoglu M, Yegin ZA, Acar K, Sucak GT. The
intensive care management process in patients with hematopoietic stem cell
transplantation and factors affecting their prognosis. Hematology. 2014
Sep;19(6):338-45
12. Merve Pamukcuoğlu, Kadir Acar, Nalan Akyürek, Gülsan Türköz Sucak. NonLeukemic Granulocytic Sarcoma Presenting with Multiple Skin Nodules and a
Retroperitoneal Mass. Turk J Hematol 2013;30:81-82
13. Merve Pamukçuoğlu, Kadir Acar, Nalan Akyürek, Gülsan Türköz Sucak A
Rare Case of Acute Leukemia Relapsing with a Granulocytic Sarcoma
Causing Ectopic Pregnancy Indian Journal of Hematology and Blood
Transfusion April 2013
14. Keser I, Suyani E, Aki SZ, Sucak AG. The positive impact of regular exercise
program on stem cell mobilization prior to autologous stem cell transplantation.
Transfus
Apher
Sci.
2013
Jul
6.
doi:pii:
S1473-0502(13)00205-X.
10.1016/j.transci.2013.06.007. [Epub ahead of print]
15. Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Ozdemir E,
Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M,
Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC. Hyper-CVAD Regimen in
Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective
Multicenter Study. Acta Haematol 2013 Jun 19;130(3):199-205.
16. Yaşar DG, Suyanı E, Özenirler S, Sucak GT. Adefovir is effective to promote
development of immunity to donor origin hepatitis B virus in an allogeneic
transplant recipient: a case report.Transplant Proc. 2013 Mar;45(2):833-4.
2
17. Keser I, Suyani E, Yosmaoglu HB, Aki SZ, Sucak AG. Acute physiological
responses to physiotherapy applications pre and post autologous stem cell
transplantation: an experimental study. Hematology. 2014 Apr;19(3):136-40.
18. Yağcı M, Yegin ZA, Akyürek N, Kayhan H, Ozkurt ZN, Sucak GT, Haznedar R.
TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic
lymphocytic leukemia. Leuk Res. 2013 Jun;37(6):665-70.
19. Sucak GT, Cakar MK, Suyanı E, Akı Z, Altındal SE, Acar K. Outcome of
autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma
patients in a centre from Turkey. Hematology. 2013 Sep;18(5):269-76.
20. Türkoğlu M, Erdem GU, Suyanı E, Sancar ME, Yalçın MM, Aygencel G, Akı
Z, Sucak G.Acute respiratory distress syndrome in patients with hematological
malignancies. Hematology. 2013 May;18(3):123-130.
21. Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS,
Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Paternity
wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the
late effects working party of the EBMT. Bone Marrow Transplant. 2013
Jun;48(6):878-9.
22. Çakar MK, Suyani E, Sucak GT, Altindal Ş, Aki SZ, Acar K, Yağci M, Rota S,
Özenirler S. HBV-related events after allogeneic hematopoetic stem cell
transplantatıon in a center from Turkey. Ann Hematol. 2013 Mar;92(3):395-402.
23. Akı ŞZ, Suyanı E, Bildacı Y, Çakar MK, Baysal NA, Sucak GT. Prognostic role
of pre-transplantation serum C-reactive protein levels in patients with acute
leukemia undergoing myeloablative allogeneic stem cell transplantation. Clin
Transplant. 2012 Sep-Oct;26(5):E513-2.
24. Akı SZ, Pamukçuoğlu M, Bağrıaçık Ü, Sucak GT. Encephalopathy: an unusual
neurologic complication of autologous hematopoietic stem cell transplant in
patients with multiple myeloma with renal failure.Leuk Lymphoma. 2013
Apr;54(4):894-6.
25. Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS,
Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects
Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor
for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey
3
of the Late Effects Working Party of the European Group for Blood and Marrow
Transplantation. Haematologica. 2013 Mar;98(3):339-45.
26. Palumbo A, Waage A, Hulin C, Beksac M, Zweegman S, Gay F, Gimsing P,
Leleu X, Wijermans P, Sucak G, Pezzatti S, Juliusson G, Pégourié B, Schaafsma
M, Galli M, Turesson I, Kolb B, van der Holt B, Baldi I, Rolke J, Ciccone G,
Wetterwald M, Lokhorst H, Boccadoro M, Rodon P, Sonneveld PSafety of
thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of
data from individual patients in six randomized trials. Haematologica. 2013
Jan;98(1):87-94.
27. Aydoğdu M, Ozyilmaz E, Köktürk N, Yeğin ZA, Özkurt ZN, Aki ZS, Sucak G.
Is there any relationship between pulmonary function tests and post-transplant
complications of allogeneic hematopoetic stem cell transplantation? Minerva
Med. 2012 Jun;103(3):189-98.
28. Suyanı E, Altındal Ş, Akı Ş, Sucak GT. Does fludarabine increase the incidence
of sinusoidal obstruction syndrome when combined with Bu/Cy during
conditioning? Clin Transplant. 2012 Mar-Apr;26(2):E85-6.
29. Sucak GT, Yaşar DG, Yegin ZA, Ergün MA, Ozkurt ZN, Aki ŞZ, Güntekin S.
The prognostic role of hemochromatosis H63D allele in allogeneic hematopoietic
stem cell transplantation. Ann Hematol. 2012 Aug;91(8):1281-7.
30. Suyanı E, Sucak GT, Erten Y, Cakar MK, Ulusal G, Yağcı M, Haznedar R.
Evaluation of multiple myeloma patients presenting with renal failure in a
university hospital in the year 2010. Ren Fail. 2012;34(2):257-62.
31. Sucak GT, Suyanı E, Baysal NA, Altındal Ş, Çakar MK, Akı ŞZ, Yeğin ZA,
Şanlıer N.The role of body mass index and other body composition parameters in
early post-transplant complications in patients undergoing allogeneic stem cell
transplantation with busulfan-cyclophosphamide conditioning. Int J Hematol.
2012 Jan;95(1):95-101.
32. Bağrıaçık EU, Yaman M, Haznedar R, Sucak G, Delibasi T. TSH-induced gene
expression involves regulation of self-renewal and differentiation-related genes in
human bone marrow-derived mesenchymal stem cells.J Endocrinol. 2012
Feb;212(2):169-78.
33. Elif Suyanı, Zeynep Akı, Zeynep Arzu Yeğin, Gülsan Türköz Sucak.
Bortezomib-Associated Severe Orthostatic Hypotension and Hyponatremia Turk
J Hematol 2012; 29: 301-302.
4
34. Zeynep Arzu Yegin, Gülsan Türköz Sucak, Gonca Erbaş, Münci Yağcı ARA-C
associated pulmonary toxicity. Turk J Hematol 2011; 28: 81-3.
35. Turkoglu M, Mirza E, Tunçcan OG, Erdem GU, Dizbay M, Yağcı M, Aygencel
G, Türköz Sucak G. Acinetobacter baumannii infection in patients with
hematologic malignancies in intensive care unit: risk factors and impact on
mortality. J Crit Care. 2011 Oct; 26(5):460-7.
36. Akı SZ, Paşaoğlu H, Yeğin ZA, Suyanı E, Demirtaş CY, Ozkurt ZN, Yağcı
M, Sucak GT. Impact of prohepcidin levels and iron parameters on early posttransplantation toxicities.Hematology. 2011 Sep;16(5):284-90.
37. Yenicesu I, Sucak G, Dilsiz G, Akı SZ, Yeğin ZA. Hematopoietic stem cell
transplantation in a very high risk group of patients with the support of
granulocyte transfusion. Indian J Hematol Blood Transfus. 2011 Sep;27(3):14651.
38. Tunçcan ÖG, Aki ŞZ, Akyürek N, Sucak G, Şenol E. Isolated cutaneous
aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell
transplantation.J Infect Dev Ctries. 2011 May 28;5(5):406-9.
39. Rota S, Fidan K, Bozdayı G, Dalgıç A, Fidan I, Sucak G, Müderris T.
[Investigation of BK and JC virus DNA positivities by real-time polymerase
chain reaction in the clinical samples of patients with high risk].Mikrobiyol Bul.
2011 Apr;45(2):280-7.
40. Suyanı E, Yağcı M, Sucak GT. Complete remission with a combination of
lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete
POEMS syndrome. Acta Haematol. 2011;126(4):199-201.
41. Sucak GT, Özkurt ZN, Suyanı E, Yaşar DG, Akdemir ÖÜ, Akı Z, Yeğin ZA,
Yağcı M, Kapucu ÖL. Early post-transplantation positron emission tomography
in patients with Hodgkin lymphoma is an independent prognostic factor with an
impact on overall survival. Ann Hematol. 2011 Nov;90(11):1329-36.
42. Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano
JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H, Gonzalez-Vicent M, Espigado I,
Halter J, Martino R, Mohty B, Sucak G, Ullmann AJ, Vázquez L, Ward KN,
Engelhard D; Infectious Diseases Working Party, European Group for Blood and
Marrow Transplantation; Infectious Complications Subcommittee, Spanish
Group of Haematopoietic Stem-cell Transplantation. Outcome of pandemic
5
H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica.
2011 Aug;96(8):1231-5.
43. Sucak GT, Aki SZ, Yüzbaşioğlu B, Akyürek N, Yağci M, Bağriaçik U,
Haznedar R. Prognostic value of bone marrow microvessel density and
angiogenic cytokines in patients with multiple myeloma undergoing autologous
stem cell transplant. Leuk Lymphoma. 2011 Jul;52(7):1281-9.
44. Yegin ZA, Paşaoğlu H, Aki SZ, Özkurt ZN, Demirtaş C, Yağci M, Acar
K, Sucak GT. Pro-oxidative/antioxidative imbalance: a key indicator of adverse
outcome in hematopoietic stem cell transplantation.Int J Lab Hematol. 2011
Aug;33(4):414-23.
45. Haznedar R, Akı ŞZ, Akdemir ÖÜ, Özkurt ZN, Çeneli O, Yağcı M, Sucak GT,
Unlü M. Value of 18F-fluorodeoxyglucose uptake in positron emission
tomography/computed tomography in predicting survival in multiple myeloma.
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1046-53.
46. Suyani E, Aki Z, Güzel Ö, Altindal S, Senol E, Sucak G.H1N1 infection in a
cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy
might be life saving.Transpl Infect Dis. 2011 Apr;13(2):208-12.
47. Sucak A, Acar K, Celen S, Danisman N, Sucak GT. Outcome of pregnancies in
women with thrombophilic disorders.J Obstet Gynaecol. 2010;30(8):847-51.
48. Suyanı E, Sucak GT, Akı ŞZ, Yeğin ZA, Özkurt ZN, Yağcı M. Gemcitabine and
vinorelbine combination is effective in both as a salvage and mobilization
regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT. Ann
Hematol. 2011 Jun;90(6):685-91.
49. Beksaç M, Haznedar R, Firatli-Tuğlular T, Özdogu H, AydoĞdu I, Konuk
N, Sucak G, Kaygusuz I, Karakus S, Kaya E, Ali R, Gulbas Z, Ozet G, Goker H,
Undar L. Addition of thalidomide to oral melphalan/prednisone in patients with
multiple myeloma not eligible for transplantation: results of a randomized trial
from the Turkish Myeloma Study Group. Eur J Haematol. 2011 Jan;86(1):16-22.
50. Sucak G, Suyanı E, Özkurt ZN, Yeğin ZA, Aki Z, Yagci M. Abnormal protein
bands in patients with multiple myeloma after haematopoietic stem cell
transplantation: does it have a prognostic significance? Hematol Oncol. 2010
Dec;28(4):180-4.
6
51. Ozyilmaz E, Aydoğdu M, Sucak G, Akı ŞZ, Özkurt ZN, Yeğin ZA, Köktürk N.
Risk factors for fungal pulmonary infections in hematopoietic stem cell
transplantation recipients: the role of iron overload. Bone Marrow Transplant.
2010 Oct;45(10):1528-33.
52. Tunçcan OG, Yegin ZA, Ozkurt ZN, Erbaş G, Akı SZ, Senol E, Yağcı
M, Sucak G. High ferritin levels are associated with hepatosplenic candidiasis in
hematopoietic stem cell transplant candidates.Int J Infect Dis. 2010 Sep;14 Suppl
3:e 104-7.
53. Suyanı E, Akı SZ, Yegin ZA, Ozkurt ZN, Altındal S, Akyürek N, Yaǧcı
M, Sucak GT. The impact of bone marrow fibrosis on the outcome of
hematopoietic stem cell transplantation.Transplant Proc. 2010 Sep;42(7):2713-9.
54. Yağcı M, Özkurt ZN, Yeğin ZA, Aki Z, Sucak GT, Haznedar R. Hepatitus B
virus reactivation in HBV-DNA negative and positive patients with
hematological malignancies. Hematology. 2010 Aug;15(4):240-4.
55. Ceneli O, Ozkurt ZN, Acar K, Rota S, Aki SZ, Yeğin ZA, Yağci M, Ozenirler
S, Sucak GT. Hepatitis B-related events in autologous hematopoietic stem cell
transplantation recipients. World J Gastroenterol. 2010 Apr 14;16(14):1765-71.
56. Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Yağci M. Iron overload: predictor of
adverse outcome in hematopoietic stem cell transplantation.Transplant Proc.
2010 Jun;42(5):1841-8.
57. Yegin ZA, Ozkurt ZN, Aki SZ, Sucak GT.Donor lymphocyte infusion for
leukemia relapse after hematopoietic stem cell transplantation.Transfus Apher
Sci. 2010 Jun;42(3):239-45.
58. Ozkurt ZN, Yegin ZA, Suyani E, Aki SZ, Acar K, Yagci M, Sucak GT. Factors
affecting stem cell mobilization for autologous hematopoietic stem cell
transplantation. J Clin Apher. 2010;25(5):280-6.
59. Olguntürk R, Kula S, Sucak GT, Ozdoğan ME, Erer D, Saygili A. Peripheric
stem cell transplantation in children with dilated cardiomyopathy: preliminary
report of first two cases. Pediatr Transplant. 2010 Mar;14(2):257-60.
60. Özkurt ZN, Yağcı M, Sucak GT, Kirazli S, Haznedar R.Thrombopoietic
cytokines and platelet count in multiple myeloma. Platelets. 2010;21(1):33-6.
61. Özkurt ZN, Yeğin ZA, Yenicesu I, Aki SZ, Yagcı M, Sucak GT. Impact of
ABO-incompatible donor on early and late outcome of hematopoietic stem cell
transplantation.Transplant Proc. 2009 Nov;41(9):3851-8.
7
62. Koçer B, Sucak G, Kuruoğlu R, Akı Z, Haznedar R, Erdoğmus NI. Clinical and
electrophysiological evaluation of patients with thalidomide-induced neuropathy.
Acta Neurol Belg. 2009 Jun;109(2):120-6.
63. Özkurt ZN, Sucak GT, Aki SZ, Yağci M, Erdem O. Bortezomib-induced
perivascular dermatitis in a patient with multiple myeloma. Cutan Ocul Toxicol.
2009;28(3):141-3.
64. Akı ŞZ, Sucak GT, Paşaoğlu H, Özkurt ZN, Yeğin ZA, Ofluoğlu E, Yağcı M,
Haznedar R. Thrombopoietic cytokine and P-selectin levels in patients with
multiple myeloma undergoing autologous stem cell transplantation: decrease in
posttransplantation P-selectin levels might predict the degree of maximum
response. Clin Lymphoma Myeloma. 2009 Jun;9(3):229-33.
65. Çetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE,
Çetiner M, Haznedar R. Osteonecrosis of the jaw in patients with multiple
myeloma treated with zoledronic acid. J Bone Miner Metab. 2009;27(4):435-43.
66. Akı ŞZ, Sucak GT, Ozkurt ZN, Yeğin ZA, Yağci M, Haznedar R. Allogeneic
stem cell transplantation for severe aplastic anemia: graft rejection remains a
problem. Transfus Apher Sci. 2009 Feb;40(1):5-11.
67. Akı Ş, Aksoy Ö, Sucak G, Kuruoğlu R, Yağcı M, Miller Fisher Syndrome
(MFS) Associated with Chronic Lymphocytic Leukemia (CLL) Neurol İndia
Neurol India. 2008 Apr-Jun;56(2):198-200.
68. Sucak GT, Özkurt ZN, Akı Z,Yağcı M, Çengel A, Haznedar R. Cardiac Systolic
Function In Patients Receiving Hematopoetic Stem Cell Transplantation; Risk
Factors
For
Posttransplant
Cardiac
Toxicity
Transplant
Proc.
2008
Jun;40(5):1586-90.
69. Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Karakan T, Akyol G. The role of liver
biopsy in the workup of liver dysfunction late after SCT: is the role of iron
overload underestimated? Bone Marrow Transplant. 2008 Oct;42(7):461-7.
70. Yenicesu I, Dilsiz G, Sucak G, Aki Z. BT-online: an innovated and promising
computer assisted transfusion system. Med Sci Monit. 2008 Aug;14(8):MT21-6
71. Eren A, Kuştimur S, Kalkanci A, Unverdi S, Aktaş F, Sucak GT. Investigation of
the effect of constructions in hospital environment on the crucial units for
immunocompromised patients and the development of opportunistic mold
infections]. Mikrobiyol Bul. 2008 Jan;42(1):83-93.
8
72. Sucak GT, Aki ZŞ, Yağcı M, Yeğin ZA, Özkurt ZN, Haznedar R. Treatment of
sinusoidal obstruction syndrome with defibrotide: a single-center experience.
Transplant Proc. 2007 Jun;39(5):1558-63.
73. Sucak GT, Akı ZŞ, Or M. Protein S deficiency with homozygous Factor V
Leiden mutation in central retinal vein occlusion Canadian Journal of
ophthalmology Can J Ophthalmol. 2007 Aug; 42(4):632-3.
74. ZA Yeğin, Akı ZŞ, Sucak GT, Yağcı M. Cytarabine induced non-cardiogenic
pulmonary edema in a case of acute lymphoblastic leukemia International
journal of Laboratory Hematology Int J Lab Hematol. 2007 Dec;29(6):482-483.
75. Yağcı M, Acar K, Sucak GT, Yamaç K, Haznedar R. Hepatitis B virus vaccine
in lymphoproliferative disorders: a prospective randomized study evaluating the
efficacy of granulocyte-macrophage colony stimulating factor as a vaccine
adjuvant. Eur J Haematol. 2007 Oct; 79(4):292-6.
76. Sucak G, Acar K, Sucak A, Kirazlı Ş, Haznedar R Increased global fibrinolytic
capacity as a clue for activated fibrinolysis in preeclampsia Blood Coagulation
and Fibrinolysis Blood Coagul Fibrinolysis. 2006 Jul; 17(5):347-352.
77. Kalkancı A, Kuştimur S, Sucak GT, Şenol E, Sugita T Adams G, Verkley G,
Summerbell R Fulminating fungal sinusitis cause by Valsa Sordida, a plant
pathogen, in a patient immunocompromised by acute leukemia Medical
Mycology Med Mycol. 2006 Sep;44(6):531-9.
78. Acar K, Yağcı M, Sucak GT, Haznedar R. Isolated prolonged activated partial
thromboplastin time in an asymptomatic patient: Fletcher factor deficiency
Thrombosis Research (Thromb Res. 2006 Jan 12; Thromb Res. 2006;118(6):7656.
79. Acar K, Sucak GT, Yağcı M, Tunca Y, Haznedar R Translocation
(2;11)(p21;q23) in apatient with Polycythemia Vera: A novel Clonal
Chromosome abnormality Am J Hematol 2006 Nov;81(11):891.
80. Yağcı M, Acar K, Sucak GT, Akı Z, Bozdayı G, Haznedar R. A prospective
study on chemotherapy induced Hepatitis B reactivation in chronic Hb S Ag
carriers with hematologicalmalignancies and preemptive therapy with nucleoside
analogues. Leukemia & Lymphoma. 2006 Aug; 47(8):1608-12.
81. Yağcı M, Akar I, Sucak GT, Haznedar R. GM-CSF does not increase CD20
antigen expression on chronic lymphocytic leukemia lymphocytes.Leuk Res.
2005 Jul;29(7):735-8
9
82. Barun S, Ertoy D, Dileköz E, Müftüoğlu S, Erten Y, Sucak G, Bali M, Tekeli N,
Sarıoğlu Y, Ercan ZS Effects of Amifostine on glycerol pretreated rabbit
kidneys. Basic & Clinical Pharmacology and Toxicology 2005; Sep;97(3):16873
83. Çeneli Ö, Sucak GT, Yağcı M, Karakan T, Isık S, Haznedar R Acute
Pancreatitis complicating treatment of granulocytic Sarcoma ; cytosine
arabinoside induced ? A case report. Haema 2005 ; 8 (2) : 293-296.
84. Yağcı M, Sucak GT, Haznedar R. Fibrinolytic activity in multiple myeloma. Am
J Hematol. 2003 Dec;74 (4):231-7.
85. Yağcı M, Sucak GT, Akyol G, Haznedar R. Hepatic failure due to CD3+ plasma
cell
infiltration of
the liver
in
multiple myeloma. Acta
Haematol.
2002;107(1):38-42.
86. Sucak GT, Yağcı M, Karakan T, Haznedar R. Unusual presentation of amebic
liver abscess with thrombocytopenia and splenomegaly. Int J Infect Dis.
2001;5(1):53-5.
87. Yağcı M, Sucak GT, Haznedar R. Red swollen nail folds and nail deformity as
presenting
findings
in
chronic
lymphocytic
leukaemia.
Br J Haematol. 2001 Jan;112(1):1
88. Yağcı M, Sucak GT, Ogur G, Haznedar R. Therapy-related refractory anemia
with ringed sideroblasts in chronic lymphocytic leukemia. involvement of 3q21
region. Cancer Genet Cytogenet. 2001 Aug; 129(1):43-6.
89. Sucak GT, Bali M, Karakan T, Haznedar R. Bilateral spontaneous perinephric
hematoma: evaluation with CT and angiography and successful conservative
treatment. Nephron. 2000 Oct;86(2):237-8.
90. Yağcı M, Sucak GT, Haznedar R. Fludarabine and risk of hepatitis B virus
reactivation in chronic lymphocytic leukemia. Am J Hematol. 2000
Jul;64(3):233-4.
91. Cihan A, Menteş B, Sucak GT, Karamercan A, Haznedar R, Ferahköşe Z.
Fournier’s Gangrene following hemorrheidectomy: Association with drug
induced agranulocytosis. Report of a case. Disease of the Colon & Rectum Dis
Colon Rectum. 1999 Dec;42(12):1644-8.
10
92. Cengiz B, Sucak GT, Kuruoğlu R, Tan E. Hypereosinophilic Syndrome:
Progression of peripheral neuropathy despite controlled eosinophil levels. Acta
Neurol Belg. 1999 Jun;99(2):133-7.
93. Sucak GT, Ogur G, Topal G, Ataoğlu Ö, Cankuş G, Haznedar R. del 17(q25) in
a patient with hairy cell leukemia : A new clonal chromosome abnormality.
Cancer Genet Cytogenet 1998; 100: 152-154.
94. Sucak GT, Cemri M, Atasever T, Uzunalimoğlu B, Dumlu Ş, Dörtlemez H.
Liver disease presenting with cyanosis. Postgraduate Medical Journal 1998; 74
(871): 317-319.
95. Sucak GT, Haznedar R, Yalçın R. Reversible cardiomyopathy in a patient with
hairy cell leukemia. Postgraduate Medical Journal 1998; 74 (871): 313-314.
96. Çakır B, Sucak GT, Haznedar R. Longitudinal nail bands during hydroxyurea
therapy. International Journal of Dermatology 1997; 36 (3): 236-237.
Yazılan Uluslararası Kitap Bölümü
Z.A. Yegin, G.T. Sucak, T. Demirer. Innovations in Stem Cell Transplantation.
Iron
Overload and Hematopoietic Stem Cell Transplantation, Chapter 14, 305-
329, 2013.
Yazılan Ulusal Kitap Bölümü
Z.A. Yegin, G.T. Sucak. Editörler: G. İliçin, K. Biberoğlu, G. Süleymanlar, S.
Ünal. Temel İç Hastalıkları 3. Baskı. (Normokrom Normositer Anemi Bölümü),
20-21pp, Ankara, Güneş Kitabevi, 2010
11